Publication | Closed Access
Bevacizumab and irinotecan for recurrent oligodendroglial tumors
71
Citations
27
References
2009
Year
This regimen is effective in recurrent oligodendrogliomas, and the overall tolerance is acceptable.
| Year | Citations | |
|---|---|---|
Page 1
Page 1